Gen-Probe Inc

Kephera Diagnostics, LLC is a biotechnology company based in Framingham, MA that specializes in developing innovative immunoassay technologies for the diagnosis of infectious diseases. Their team of experts collaborates with renowned institutions such as the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) to bring accurate diagnostic solutions to clinicians and patients worldwide. With a focus on emerging and neglected diseases of global significance, Kephera Diagnostics offers both lab-based and point-of-care tests for infectious diseases like Lyme disease, neurocysticercosis, liver fluke infection, Chagas disease, and Zika virus. Their CLIA-certified clinical lab ensures accurate test results, providing valuable insights for the diagnosis and management of these infectious diseases.Generated from the website

HelixBind, Inc., based in Boxborough, MA, is pioneering an innovative diagnostic platform aimed at transforming the care of bloodstream infections. Their proprietary technology delivers faster, more accurate, and informative microbiology results, enabling clinicians to precisely identify invasive infections and tailor antimicrobial interventions for patients. Addressing the critical challenge of sepsis, which affects millions globally, HelixBind's platform provides results in just four hours compared to the traditional blood culture tests that take up to 23 days. By facilitating rapid identification and characterization of infections, the company aims to improve patient outcomes and combat the spread of antimicrobial resistance. Generated from the website